MedTrace Logo

Piloting Visual Chat in Internet Obesity Treatment

NCT03491293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-12-06

No results posted yet for this study

Summary

CHAT is an internet-based weight loss research program designed for women with overweight or obesity who want to lose weight through dietary change and increased physical activity. Participants will be randomized into a group-based online program who meet via a text chat or a video chat.

Conditions

Interventions

BEHAVIORAL

Behavioral Weight Loss + Text

Participants will attend weekly one hour classes on line. They will type their input and responses within the chat room. They will record their calorie and fat intake daily and weigh themselves daily. Interventionists will review the diaries weekly and provide feedback to reinforce or shape new behaviors and to identify high risk situations for problem solving.

BEHAVIORAL

Behavioral Weight Loss + Video

Participants will attend weekly one hour classes on line. They will have audio and video within the chat room, and will talk with their facilitator and classmates during their weekly meeting. They will record their calorie and fat intake daily and weigh themselves daily. Interventionists will review the diaries weekly and provide

Sponsors & Collaborators

  • University of South Carolina

    collaborator OTHER

  • University of Tennessee

    collaborator OTHER

  • University of Vermont

    lead OTHER

Principal Investigators

  • Jean Harvey, PhD RDN · University of Vermont

  • Delia West, PhD · University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-06
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491293 on ClinicalTrials.gov